Parameters
Current asthma n = 26 (53%) No asthma n = 23 (47%) Statistical significance* p OR (95% CI)
Serum total IgE, kU/L, median (IQR)# 28.0 (3.5-87.75) 9.0 (1.0-46.5) 0.247
Serum total IgE ≥60 kU/L, n, (%)
7/24 (29.2%)
4/21 (19.0%)
0.431 1.75 (0.43-7.10)
Specific IgE to inhaled allergens, n, (%)
5/22 (22.7%)
3/20 (15.0%)
0.667 1.67 (0.34-8.10)
Specific IgE to food allergens, n, (%)
9/22 (40.9%)
7/20 (35.0%)
0.694 1.29 (0.37-4.50)
Blood eosinophils × 109/L, median (IQR)&
0.43 (0.12-0.70)
0.14 (0.07-0.34)
0.023
Eosinophils ≥ 0.45 × 109/L, n, (%)
10/24 (41.7%)
3/22 (13.6%)
0.043 5.52 (1.05-19.54)
Serum ECP, µg/L, median (IQR)£
4.5 (2.2-9.4)
4.5 (2.3-8.0)
0.836
Nasopharyngeal ECP, ng/g, median (IQR)& 347 (171-565) 498 (216-991) 0.140
Serum ECP ≥16 µg/L, n, (%)
4/25 (16.0%)
3/23 (13.0%)
0.772 1.27 (0.252-6.40)
Nasopharyngeal ECP ≥ 870 ng/g, n, (%)
4/23 (17.4%)
6/23 (26.1%)
0.475 0.60 (01.14-2.48)